Sorted By:

Relevance


The Big Picture in Drug Development

PhRMA  |  Blog Post

We think our animated drug discovery timeline really helps capture the big picture.
http://catalyst.phrma.org/the-big-picture-in-drug-development

Privacy Policy

PhRMA  |  From PhRMA

Social Networking Services PhRMA has worked with certain third-party social media providers to offer you their social networking services through our Services. 
https://www.phrma.org/privacy-policy

What is a Biomarker?

Chartpack  |  From Our Network

Learn more about how biomarkers inform medical decisions here.
http://chartpack.phrma.org/personal-medicines-in-development-chartpack/a-new-treatment-paradigm/what-is-a-biomarker

More Than 400 Innovative Medicines in Development For Top Chronic Diseases Affecting Older Americans

PhRMA  |  Press Release

  The Medicines in Development for Older Americans report as well as an overview and other supplementary materials are available on PhRMA’s website at http://phrma.org/innovation/meds-in-development   The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research and biotechnology companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/more-than-400-innovative-medicines-in-development-for-top-chronic-diseases-affecting-older-americans

Rx Response Director Erin Mullen Receives Outstanding Achievement Award

PhRMA  |  Press Release

Widespread media coverage of the PSRT following Sandy quadrupled traffic to the online tool.
https://www.phrma.org/press-release/rx-response-director-erin-mullen-receives-outstanding-achievement-award

#pass4prostate: Tackling Prostate Cancer through Awareness, Research

PhRMA  |  Blog Post

In partnership with USA Rugby and the Australian Rugby Union, we’ve launched #pass4prostate, a social media effort designed to raise awareness of the impact prostate cancer has on far too many people, as well as the importance of continued research and advocacy.
http://catalyst.phrma.org/pass4prostate-tackling-prostate-cancer-through-awareness-research

Patients and Scientists Headline PhRMA’s “From Hope to Cures” Ad Campaign

PhRMA  |  Press Release

 The “From Hope to Cures” campaign seeks to educate health care stakeholders, opinion leaders, policymakers and members of the media on the following key areas:  The value medicines provide to patients; The role of biopharmaceutical innovation in creating a more sustainable health care system; The long, costly and complex process to develop a new medicine, test it and bring it to the market; and The role the biopharmaceutical industry plays as a job creator and engine of economic growth.
https://www.phrma.org/press-release/patients-and-scientists-headline-phrma-s-from-hope-to-cures-ad-campaign

PhRMA Statement on Prescription Drug Importation

PhRMA  |  Press Release

For more information about the worldwide counterfeit threat, go to www.buysafedrugs.info.
https://www.phrma.org/press-release/phrma-statement-on-prescription-drug-importation

Why neglected tropical disease and rare disease researchers need each other

PhRMA  |  Blog Post

   Sadly, we are hearing a lot about babies and their head size in the media lately, but in the other direction – children being born with microcephaly.
http://catalyst.phrma.org/why-neglected-tropical-disease-and-rare-disease-researchers-need-each-other

Second Annual PhRMA Survey: How Americans View Their Health, Three Important New Health Trends to Watch

PhRMA  |  Blog Post

Read the related press release
http://catalyst.phrma.org/second-annual-phrma-survey-how-americans-view-their-health-three-important-new-health-trends-to-watch

PhRMA Statement on New Strategic Plan from the IP Enforcement Coordinator

PhRMA  |  Press Release

“As IPEC continues its work, we encourage the Administration to use every opportunity to ensure that countries such as India respect, protect, and enforce intellectual property rights. 
https://www.phrma.org/press-release/phrma-statement-on-new-strategic-plan-from-the-ip-enforcement-coordinator

Better Use of Medicines Yields Significant Health Gains and Savings on Other Services

Chartpack  |  From Our Network

Due to a growing body of evidence, in 2012 the Congressional Budget Office (CBO) began recognizing reductions in other medical expenditures associated with increased use of prescription medicines in Medicare.
http://chartpack.phrma.org/biophrma-chartpack/outcomes-and-savings/better-use-of-medicines-yields-significant-health-gains-and-savings-on-other-services

More than 430 Medicines in Development to Treat Chronic Diseases Affecting Older Americans

PhRMA  |  Blog Post

Earlier this week, PhRMA released a new report detailing the medicines in development for older Americans, including treatments for arthritis, Alzheimer’s disease, cardiovascular disease, and diabetes.
http://catalyst.phrma.org/more-than-430-medicines-in-development-to-treat-chronic-diseases-affecting-older-americans

Sharing a Story of Hope

PhRMA  |  Blog Post

Follow us on social media!
http://catalyst.phrma.org/sharing-a-story-of-hope

New non-discrimination rule neglects to define discriminatory benefits

PhRMA  |  Blog Post

Med. 399, 401 (2015), available at http://www.nejm.org/doi/pdf/10.1056/NEJMp1411376.
http://catalyst.phrma.org/new-non-discrimination-rule-neglects-to-define-discriminatory-benefits

A Comparative Analysis of the Role and Impact of Health Technology Assessment

PhRMA  |  Report

However, it is also possible that a poorly designed or managed HTA process runs the risk of denying patients appropriate access to medical technologies, inefficiently allocating resources, constraining clinical freedom and sending distorted signals to medical technology providers.
https://www.phrma.org/report/a-comparative-analysis-of-the-role-and-impact-of-health-technology-assessment

Research & Hope Awards

PhRMA  |  Press Release

Media partners for this year’s program are: WUSA-9, BioCentury Publications, “The Pink Sheet,” Pharmaceutical Executive, pharmaphorum and SCRIP Intelligence.
https://www.phrma.org/press-release/research-and-hope-awards

PDUFA V Sets New Course for Regulatory Science – Joint BIO/PhRMA Statement

PhRMA  |  Press Release

The Agency also will have dedicated resources to evaluate the use of meta-analyses and provide guidance on standardized methodologies for their use in drug review and safety monitoring.
https://www.phrma.org/press-release/pdufa-v-sets-new-course-for-regulatory-science-joint-bio/phrma-statement

Guest Post: Epilepsy Foundation on rare diseases

PhRMA  |  Blog Post

The number of people with epilepsy who don’t have their seizures under control hasn’t changed, despite significant advances in the development of innovative anti-seizure medications, medical devices, and surgical options over the past several years.
http://catalyst.phrma.org/guest-post-epilepsy-foundation-on-rare-diseases

The Coming Alzheimer's Catastrophe

PhRMA  |  Blog Post

America's biopharmaceutical research companies are now working on nearly 100 new treatments to fight Alzheimer's.
http://catalyst.phrma.org/the-coming-alzheimers-catastrophe

A New World of Medicine: New GOBOLDLY ads showcase groundbreaking scientific advancements

PhRMA  |  Blog Post

Both New World and Together illustrate the incredible innovation happening in medical science and how industry scientists are changing the way we treat the most complex and debilitating diseases.
http://catalyst.phrma.org/new-world-of-medicine

Medicare Monday: Managing Chronic Conditions

PhRMA  |  Blog Post

In 2014, biopharmaceutical research companies had more than 430 medicines in development targeting chronic conditions affecting seniors.
http://catalyst.phrma.org/medicaremonday-managing-chronic-conditions

Week in Review: Planning Ahead for Patients

PhRMA  |  Blog Post

As noted in our Medicines in Development reports, the research and development (R&D) of new treatments can be an arduous process, averaging 10-15 years and $2.6 billion.
http://catalyst.phrma.org/week-in-review-planning-ahead-for-patients

Researching Cancer Medicines: Setbacks and Stepping Stones

PhRMA  |  Report

While recent scientific advances have led to improved prevention, earlier diagnoses, and innovative treatments for many cancers, there is still tremendous unmet medical need.
https://www.phrma.org/report/researching-cancer-medicines-setbacks-and-stepping-stones

PhRMA Statement on Sunshine Proposed Rule

PhRMA  |  Press Release

Find PhRMA Online: Website – http://www.phrma.org facebook – www.facebook.com/PhRMA Blog – www.phrma.org/catalyst Twitter – www.Twitter.com/PhRMA and www.Twitter.com/PhRMApress YouTube – www.youtube.com/PhRMApress For information on how innovative medicines save lives, visit: http://www.innovation.org For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org For information on ensuring the flow of medicines during public health emergencies, visit http://www.rxresponse.org
https://www.phrma.org/press-release/phrma-statement-on-sunshine-proposed-rule

You have reviewed the first 425 results out of 1046. Each page contains 25 results. You're on page 17.

prev 13 14 15 16 17 18 next